Dolastatin 10 in Treating Patients With Indolent Lymphoma, Waldenstrom's Macroglobulinemia, or Chronic Lymphocytic Leukemia
Clinical trial NCT00005579 · COMPLETED
Trial details
- NCT number
- NCT00005579
- Sponsor
- University of Vermont
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-06-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.